Celebrating pioneers in women’s cancer research and treatment

The Femtech World Awards are set to recognise the people, organisations and innovations revolutionising how we treat and diagnose cancer in women.

Now in its third year, the Femtech World Awards celebrates the very best of female-led and focused health innovation, spanning menopause, fertility, cardiovascular disease and beyond.

The Women’s Cancer Innovation award will honour a groundbreaking innovation dedicated to the prevention, early detection treatment or ongoing care of cancers that uniquely or disproportionately affect women.

The winner will have demonstrated exceptional progress in advancing research, technology or patient-centred solutions that improve outcomes and quality of life.

This award celebrates those driving transformative change in the fight against women’s cancers.

The Women’s Cancer Innovation Award is sponsored by Endomag.

Endomag believes everyone deserves a better standard of cancer care – that’s why they design their cancer localisation technologies with both the clinician and patient in mind.

Many leading hospitals across the world use their unique solutions to help breast cancer patients avoid surgery when it isn’t needed, and experience better outcomes when it is.

Their Magseed marker is a tiny, non-radioactive seed, ideal for accurately marking tumours and lymph nodes, while the Magtrace lymphatic tracer is the world’s first, long-lasting, non-radioactive dual tracer for lymphatic mapping.

Paired with the Sentimag localisation platform, they have now been widely proven across over 200 clinical studies, featuring more than 20,000 patients.

This award is one of 10 featuring at the event, which last year attracted entries from across the UK, Europe and North America.

Award winners will receive a trophy and the opportunity to be interviewed by Femtech World.

Both winners and shortlisted entries will receive extensive coverage across all Femtech World platforms.

Find out more and enter for free here.